Showing results (21-30 of 69) with videos related to
Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2011
A phase I study in adults of clofarabine combined with high-dose melphalan as reduced-intensity conditioning for allogeneic transplantationMark H Kirschbaum, Anthony S Stein, Leslie Popplewell, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 19, 2018
Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD ProphylaxisAmandeep Salhotra, Matthew Mei, Tracey Stiller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2010
Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple myelomaGeorge Somlo, Ricardo Spielberger, Paul Frankel, et al.Clinical Lymphoma, Myeloma & Leukemia|February 13, 2022
Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib StudyMaria Lia Palomba, Guillaume Cartron, Leslie Popplewell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and mantle cell lymphomaMark Kirschbaum, Paul Frankel, Leslie Popplewell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell LymphomaJoseph M Tuscano, Emanual Maverakis, Susan Groshen, et al.Transplantation and Cellular Therapy|May 20, 2026
High incidence of cytomegalovirus infection in patients receiving standard of care CD19- or BCMA-targeted CAR T-cell therapies for hematologic malignanciesTamer Othman, John H Baird, Yan Wang, et al.Leukemia & Lymphoma|April 15, 2021
Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphomaWyndham H Wilson, Tycel Phillips, Leslie Popplewell, et al.Blood Advances|August 30, 2024
Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trialAmitkumar Mehta, Leslie Popplewell, Graham P Collins, et al.The Oncologist|August 16, 2017
Are Disagreements in Caregiver and Patient Assessment of Patient Health Associated with Increased Caregiver Burden in Caregivers of Older Adults with Cancer?Tina Hsu, Matthew Loscalzo, Rupal Ramani, et al.Pageof 7